Skip to content
← Childhood Acute Lymphoblastic Leukemia

NCT00357565 · STUDY IN CONTEXT

Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia

Draft scope assessment: narrower. Linked by condition-string match at the cancer-entity level. The study's eligibility - stage, biomarker, treatment line and prior therapy - has not been reconciled against this page's definition, so its population is narrower than this page in ways not yet recorded. The condition was transformed or resolved through the terminology hierarchy to reach this cancer type, so the link itself is a candidate a reviewer must confirm. Found by searching ClinicalTrials.gov for this cancer type, restricted to studies that have posted results to the registry. No FDA notice, FDA label or NCI summary held by this site cites this study. Because the search asked for posted results, studies without posted results were never looked for, so their absence from this page means nothing.

Read the full study record and all posted results →

Linked outcomes

Measures are not ranked. Open each original source section for treatment groups, denominators, units and results.

Reported safety

Serious events are not the same as severe events. Compare the original safety groups and their at-risk populations.

Open the study safety table →

Quality of life and patient-reported measures

No linked quality-of-life measure is recorded for this setting and study.

Full draft applicability and source-link record
trial
release id
clinical-indications-draft-1
disease state id
ds-acute-lymphoblastic-leukemia-pediatric
nct id
NCT00357565
trial label
Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia
applicability
narrower
applicability note
Linked by condition-string match at the cancer-entity level. The study's eligibility - stage, biomarker, treatment line and prior therapy - has not been reconciled against this page's definition, so its population is narrower than this page in ways not yet recorded. The condition was transformed or resolved through the terminology hierarchy to reach this cancer type, so the link itself is a candidate a reviewer must confirm.
curation status
draft
reviewed by
Source null
reviewed at
Source null
created at
2026-09-10T00:00:00Z
provenance class
registry-condition-search
discovery note
Found by searching ClinicalTrials.gov for this cancer type, restricted to studies that have posted results to the registry. No FDA notice, FDA label or NCI summary held by this site cites this study. Because the search asked for posted results, studies without posted results were never looked for, so their absence from this page means nothing.
outcome Count
6
harms Count
3
qol Count
0
outcomes
  1. release id
    clinical-indications-draft-1
    disease state id
    ds-acute-lymphoblastic-leukemia-pediatric
    nct id
    NCT00357565
    outcome key
    om-0000
    source section id
    NCT00357565-om-0000
    source outcome index
    0
    endpoint
    Incidence of Engraftment
    endpoint definition
    Defined as achieving donor derived neutrophil count \>500/uL by day 42 in young children with leukemia or myelodysplastic syndrome undergoing a partially matched single unit umbilical cord blood transplant (UCBT) after a myeloablative preparative regimen consisting of busulfan, melphalan and fludarabine.
    time origin
    Day 42 After Transplant
    analysis role
    primary
    reporting status
    POSTED
    data cutoff
    Source null
    population note
    Source null
    curation status
    draft
    reviewed by
    Source null
    reviewed at
    Source null
    created at
    2026-09-10T00:00:00Z
  2. release id
    clinical-indications-draft-1
    disease state id
    ds-acute-lymphoblastic-leukemia-pediatric
    nct id
    NCT00357565
    outcome key
    om-0001
    source section id
    NCT00357565-om-0001
    source outcome index
    1
    endpoint
    Incidence of Transplant-related Mortality (TRM)
    endpoint definition
    defined as death due to transplant
    time origin
    at 6 months after transplant
    analysis role
    secondary
    reporting status
    POSTED
    data cutoff
    Source null
    population note
    Source null
    curation status
    draft
    reviewed by
    Source null
    reviewed at
    Source null
    created at
    2026-09-10T00:00:00Z
  3. release id
    clinical-indications-draft-1
    disease state id
    ds-acute-lymphoblastic-leukemia-pediatric
    nct id
    NCT00357565
    outcome key
    om-0002
    source section id
    NCT00357565-om-0002
    source outcome index
    2
    endpoint
    Incidence of Platelet Engraftment
    endpoint definition
    defined as platelet count \> 50,000
    time origin
    at 1 year after transplant
    analysis role
    secondary
    reporting status
    POSTED
    data cutoff
    Source null
    population note
    Source null
    curation status
    draft
    reviewed by
    Source null
    reviewed at
    Source null
    created at
    2026-09-10T00:00:00Z
  4. release id
    clinical-indications-draft-1
    disease state id
    ds-acute-lymphoblastic-leukemia-pediatric
    nct id
    NCT00357565
    outcome key
    om-0003
    source section id
    NCT00357565-om-0003
    source outcome index
    3
    endpoint
    Incidence of Acute Graft-versus-host Disease (GVHD) Grade II-IV and Grade III-IV
    endpoint definition
    Graft-versus-host disease (GVHD) is a common complication of allogeneic bone marrow transplantation in which functional immune cells in the transplanted marrow recognize the recipient as "foreign" and mount an immunologic attack.
    time origin
    Day 100 After Transplant
    analysis role
    secondary
    reporting status
    POSTED
    data cutoff
    Source null
    population note
    Source null
    curation status
    draft
    reviewed by
    Source null
    reviewed at
    Source null
    created at
    2026-09-10T00:00:00Z
  5. release id
    clinical-indications-draft-1
    disease state id
    ds-acute-lymphoblastic-leukemia-pediatric
    nct id
    NCT00357565
    outcome key
    om-0004
    source section id
    NCT00357565-om-0004
    source outcome index
    4
    endpoint
    Incidence of Chronic Graft-versus-host Disease (GVHD)
    endpoint definition
    Graft-versus-host disease (GVHD) is a common complication of allogeneic bone marrow transplantation in which functional immune cells in the transplanted marrow recognize the recipient as "foreign" and mount an immunologic attack.
    time origin
    1 Year After Transplant
    analysis role
    secondary
    reporting status
    POSTED
    data cutoff
    Source null
    population note
    Source null
    curation status
    draft
    reviewed by
    Source null
    reviewed at
    Source null
    created at
    2026-09-10T00:00:00Z
  6. release id
    clinical-indications-draft-1
    disease state id
    ds-acute-lymphoblastic-leukemia-pediatric
    nct id
    NCT00357565
    outcome key
    om-0005
    source section id
    NCT00357565-om-0005
    source outcome index
    5
    endpoint
    Incidence of Relapse
    endpoint definition
    defined using standard criteria (bone marrow blast count and cytogenetics).
    time origin
    1 and 2 years after transplant
    analysis role
    secondary
    reporting status
    POSTED
    data cutoff
    Source null
    population note
    Source null
    curation status
    draft
    reviewed by
    Source null
    reviewed at
    Source null
    created at
    2026-09-10T00:00:00Z
arms
  1. release id
    clinical-indications-draft-1
    disease state id
    ds-acute-lymphoblastic-leukemia-pediatric
    nct id
    NCT00357565
    outcome key
    om-0000
    arm key
    OG000
    arm label
    Double Unit UCB Transplantation
    regimen
    Patients that receive 2 units of umbilical cord blood transplantation (UCBT).
    analyzed count
    15
    analyzed unit
    Participants
    is comparator
    Source null
    source pointer
    NCT00357565-om-0000#groups/OG000
  2. release id
    clinical-indications-draft-1
    disease state id
    ds-acute-lymphoblastic-leukemia-pediatric
    nct id
    NCT00357565
    outcome key
    om-0000
    arm key
    OG001
    arm label
    Single Unit UCB Transplantation
    regimen
    Patients that receive one unit of umbilical cord blood transplantation (only if 2 adequate size and matched units are not available).
    analyzed count
    15
    analyzed unit
    Participants
    is comparator
    Source null
    source pointer
    NCT00357565-om-0000#groups/OG001
  3. release id
    clinical-indications-draft-1
    disease state id
    ds-acute-lymphoblastic-leukemia-pediatric
    nct id
    NCT00357565
    outcome key
    om-0000
    arm key
    OG002
    arm label
    BM Transplantation
    regimen
    Blood and Marrow transplantation
    analyzed count
    4
    analyzed unit
    Participants
    is comparator
    Source null
    source pointer
    NCT00357565-om-0000#groups/OG002
  4. release id
    clinical-indications-draft-1
    disease state id
    ds-acute-lymphoblastic-leukemia-pediatric
    nct id
    NCT00357565
    outcome key
    om-0001
    arm key
    OG000
    arm label
    Double Unit UCB Transplantation
    regimen
    Patients that receive 2 units of umbilical cord blood transplantation (UCBT).
    analyzed count
    15
    analyzed unit
    Participants
    is comparator
    Source null
    source pointer
    NCT00357565-om-0001#groups/OG000
  5. release id
    clinical-indications-draft-1
    disease state id
    ds-acute-lymphoblastic-leukemia-pediatric
    nct id
    NCT00357565
    outcome key
    om-0001
    arm key
    OG001
    arm label
    Single Unit UCB Transplantation
    regimen
    Patients that receive one unit of umbilical cord blood transplantation (only if 2 adequate size and matched units are not available).
    analyzed count
    15
    analyzed unit
    Participants
    is comparator
    Source null
    source pointer
    NCT00357565-om-0001#groups/OG001
  6. release id
    clinical-indications-draft-1
    disease state id
    ds-acute-lymphoblastic-leukemia-pediatric
    nct id
    NCT00357565
    outcome key
    om-0001
    arm key
    OG002
    arm label
    BM Transplantation
    regimen
    Blood and Marrow transplantation
    analyzed count
    4
    analyzed unit
    Participants
    is comparator
    Source null
    source pointer
    NCT00357565-om-0001#groups/OG002
  7. release id
    clinical-indications-draft-1
    disease state id
    ds-acute-lymphoblastic-leukemia-pediatric
    nct id
    NCT00357565
    outcome key
    om-0002
    arm key
    OG000
    arm label
    Double Unit UCB Transplantation
    regimen
    Patients that receive 2 units of umbilical cord blood transplantation (UCBT).
    analyzed count
    15
    analyzed unit
    Participants
    is comparator
    Source null
    source pointer
    NCT00357565-om-0002#groups/OG000
  8. release id
    clinical-indications-draft-1
    disease state id
    ds-acute-lymphoblastic-leukemia-pediatric
    nct id
    NCT00357565
    outcome key
    om-0002
    arm key
    OG001
    arm label
    Single Unit UCB Transplantation
    regimen
    Patients that receive one unit of umbilical cord blood transplantation (only if 2 adequate size and matched units are not available).
    analyzed count
    15
    analyzed unit
    Participants
    is comparator
    Source null
    source pointer
    NCT00357565-om-0002#groups/OG001
  9. release id
    clinical-indications-draft-1
    disease state id
    ds-acute-lymphoblastic-leukemia-pediatric
    nct id
    NCT00357565
    outcome key
    om-0002
    arm key
    OG002
    arm label
    BM Transplantation
    regimen
    Blood and Marrow transplantation
    analyzed count
    4
    analyzed unit
    Participants
    is comparator
    Source null
    source pointer
    NCT00357565-om-0002#groups/OG002
  10. release id
    clinical-indications-draft-1
    disease state id
    ds-acute-lymphoblastic-leukemia-pediatric
    nct id
    NCT00357565
    outcome key
    om-0003
    arm key
    OG000
    arm label
    Double Unit UCB Transplantation
    regimen
    Patients that receive 2 units of umbilical cord blood transplantation (UCBT).
    analyzed count
    15
    analyzed unit
    Participants
    is comparator
    Source null
    source pointer
    NCT00357565-om-0003#groups/OG000
  11. release id
    clinical-indications-draft-1
    disease state id
    ds-acute-lymphoblastic-leukemia-pediatric
    nct id
    NCT00357565
    outcome key
    om-0003
    arm key
    OG001
    arm label
    Single Unit UCB Transplantation
    regimen
    Patients that receive one unit of umbilical cord blood transplantation (only if 2 adequate size and matched units are not available).
    analyzed count
    15
    analyzed unit
    Participants
    is comparator
    Source null
    source pointer
    NCT00357565-om-0003#groups/OG001
  12. release id
    clinical-indications-draft-1
    disease state id
    ds-acute-lymphoblastic-leukemia-pediatric
    nct id
    NCT00357565
    outcome key
    om-0003
    arm key
    OG002
    arm label
    BM Transplantation
    regimen
    Blood and Marrow transplantation
    analyzed count
    4
    analyzed unit
    Participants
    is comparator
    Source null
    source pointer
    NCT00357565-om-0003#groups/OG002
harms
  1. release id
    clinical-indications-draft-1
    disease state id
    ds-acute-lymphoblastic-leukemia-pediatric
    nct id
    NCT00357565
    harm key
    EG000
    source section id
    NCT00357565-ae
    event group key
    EG000
    event group label
    Double Unit UCB Transplantation
    serious affected
    8
    serious at risk
    15
    other affected
    15
    other at risk
    15
    frequency threshold
    0
    collection period
    2 years
    event definition
    Source null
    undenominated note
    Source null
    curation status
    draft
    reviewed by
    Source null
    reviewed at
    Source null
    created at
    2026-09-10T00:00:00Z
  2. release id
    clinical-indications-draft-1
    disease state id
    ds-acute-lymphoblastic-leukemia-pediatric
    nct id
    NCT00357565
    harm key
    EG001
    source section id
    NCT00357565-ae
    event group key
    EG001
    event group label
    Single Unit UCB Transplantation
    serious affected
    5
    serious at risk
    15
    other affected
    15
    other at risk
    15
    frequency threshold
    0
    collection period
    2 years
    event definition
    Source null
    undenominated note
    Source null
    curation status
    draft
    reviewed by
    Source null
    reviewed at
    Source null
    created at
    2026-09-10T00:00:00Z
  3. release id
    clinical-indications-draft-1
    disease state id
    ds-acute-lymphoblastic-leukemia-pediatric
    nct id
    NCT00357565
    harm key
    EG002
    source section id
    NCT00357565-ae
    event group key
    EG002
    event group label
    BM Transplantation
    serious affected
    1
    serious at risk
    4
    other affected
    4
    other at risk
    4
    frequency threshold
    0
    collection period
    2 years
    event definition
    Source null
    undenominated note
    Source null
    curation status
    draft
    reviewed by
    Source null
    reviewed at
    Source null
    created at
    2026-09-10T00:00:00Z
quality of life
    setting source links

      Preserved source evidence · Not medical advice